Daiichi Sankyo (OTCMKTS:DSNKY) Reaches New 52-Week Low – Here’s What Happened

Daiichi Sankyo Co., Ltd. – Sponsored ADR (OTCMKTS:DSNKY)’s share price reached a new 52-week low on Tuesday . The company traded as low as $20.25 and last traded at $20.49, with a volume of 86885 shares changing hands. The stock had previously closed at $20.92.

Wall Street Analyst Weigh In

Separately, Zacks Research downgraded shares of Daiichi Sankyo from a “hold” rating to a “strong sell” rating in a research report on Wednesday, November 19th. One analyst has rated the stock with a Strong Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Daiichi Sankyo has an average rating of “Moderate Buy”.

Daiichi Sankyo Stock Down 1.9%

The company has a debt-to-equity ratio of 0.06, a current ratio of 2.31 and a quick ratio of 1.60. The firm has a market capitalization of $38.89 billion and a P/E ratio of 19.37. The business has a 50 day moving average price of $22.31 and a 200 day moving average price of $23.67.

Daiichi Sankyo Company Profile

Daiichi Sankyo Co, Ltd. is a global, research-driven pharmaceutical company headquartered in Tokyo, Japan. The company was formed through the merger of Daiichi Pharmaceutical and Sankyo in 2005 and focuses on the discovery, development, manufacturing and commercialization of prescription medicines. Its therapeutic priorities include oncology and cardiovascular disease, and it pursues a mix of small molecules, biologics and antibody‑drug conjugates in its development programs.

Daiichi Sankyo is known for building a development portfolio through both internal research and collaborative partnerships.